TNFSF14 Antikörper (AA 61-170)
TNFSF14
Reaktivität: Human
WB, ELISA, IP, IHC (p)
Wirt: Maus
Monoclonal
4E3
unconjugated
Produktnummer ABIN7477811
-
-
Target
Alle TNFSF14 Antikörper anzeigen
-
TNFSF14
(Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
-
Bindungsspezifität
-
AA 61-170
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Monoklonal
-
Konjugat
-
Dieser TNFSF14 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA, Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
-
Verwendungszweck
-
Mouse monoclonal antibody raised against a partial recombinant TNFSF14.
-
Sequenz
-
LHWRLGEMVT RLPDGPAGSW EQLIQERRSH EVNPAAHLTG ANSSLTGSGG PLLWETQLGV AFLRGLSYHD GALVVTKAGY YYIYSKVQLG GVGCPLGLAS TITHGLYKRT
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody Reactive Against Recombinant Protein.
-
Immunogen
-
TNFSF14 (AAH18058, 61 a.a. ~ 170 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Klon
-
4E3
-
Isotyp
-
IgG2a
-
Top Product
-
Discover our top product TNFSF14 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Buffer
-
In 1x PBS, pH 7.4
-
Handhabung
-
Aliquot to avoid repeated freezing and thawing.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Target
-
TNFSF14
(Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
-
Andere Bezeichnung
-
TNFSF14 (TNFSF14 Produkte)
-
Synonyme
-
TNFSF14 antikoerper, CD258 antikoerper, HVEML antikoerper, LIGHT antikoerper, LTg antikoerper, TR2 antikoerper, HVEM-L antikoerper, Ly113 antikoerper, TNF superfamily member 14 antikoerper, tumor necrosis factor (ligand) superfamily, member 14 antikoerper, TNFSF14 antikoerper, Tnfsf14 antikoerper
-
Hintergrund
-
Full Gene Name: tumor necrosis factor (ligand) superfamily, member 14
Synonyms: CD258,HVEML,LIGHT,LTg,TR2
-
Gen-ID
-
8740
-
Pathways
-
Cancer Immune Checkpoints
-